Why Juno Therapeutics Inc. Tanked on Thursday

What happened Juno Therapeutics NASDAQ JUNO ended down 10 6 on Thursday after announcing Wednesday after the bell that the biotech was discontinuing development of its lead treatment JCAR015 So what This shouldn t have come as much of a shock to investors JCAR015 has